Activating Parkin-dependent mitophagy alleviates oxidative stress, apoptosis, and promotes random-pattern skin flaps survival.
Zhengtai ChenHongqiang WuJianxin YangBaolong LiJian DingSheng ChengNageeb BsoulChenxi ZhangJiaorong LiHai-Xiao LiuDamu LinWei-Yang GaoPublished in: Communications biology (2022)
The random-pattern skin flap is a crucial technique in reconstructive surgery and flap necrosis caused by ischemia/reperfusion injury is a major postoperative complication. Herein, we investigated the mechanism of mitophagy induced by Melatonin (ML) and its effect on the survival of skin flaps. Our results demonstrated that ML could activate mitophagy, ameliorate oxidative stress and alleviate apoptosis in Tert-Butyl hydroperoxide solution (TBHP)-stimulated human umbilical vein endothelial cells in vitro. Inhibiting ML-induced mitophagy considerably abolished its protective effects. Moreover, knockdown of Parkin by siRNA inhibited ML-induced mitophagy, and subsequently exacerbated oxidative stress and apoptosis. Further study demonstrated that inhibition of AMPK reversed these protective effects of ML and downregulated the expression of TFEB. In the vivo study, ML effectively promoted flap survival by activating mitophagy and subsequently ameliorating oxidative stress and mitigating apoptosis. These results established that ML is a potent agent capable for increasing random-pattern skin flap survival by activating Parkin-dependent mitophagy through the AMPK-TFEB signaling pathway.
Keyphrases
- mass spectrometry
- oxidative stress
- soft tissue
- diabetic rats
- ischemia reperfusion injury
- signaling pathway
- nlrp inflammasome
- induced apoptosis
- breast reconstruction
- dna damage
- high resolution
- high glucose
- endothelial cells
- endoplasmic reticulum stress
- cell cycle arrest
- pi k akt
- free survival
- wound healing
- cell death
- epithelial mesenchymal transition
- skeletal muscle
- minimally invasive
- protein kinase
- cancer therapy
- heat shock
- mouse model
- acute coronary syndrome
- vascular endothelial growth factor
- hyaluronic acid